Jia Fan
Affiliations: | New York University, New York, NY, United States |
Google:
"Jia Fan"Mean distance: 14.06 (cluster 6) | S | N | B | C | P |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Tao CY, Wu XL, Song SS, et al. (2024) Downregulation of GPX8 in hepatocellular carcinoma: impact on tumor stemness and migration. Cellular Oncology (Dordrecht) |
| Li ZC, Wang J, Liu HB, et al. (2024) Proteomic and metabolomic features in patients with HCC responding to lenvatinib and anti-PD1 therapy. Cell Reports. 43: 113877 |
| Xie P, Yu M, Zhang B, et al. (2024) CRKL dictates anti-PD-1 resistance by mediating tumor-associated neutrophil infiltration in hepatocellular carcinoma. Journal of Hepatology |
| Hong W, Zhang Y, Wang S, et al. (2024) RECQL4 Inhibits Radiation-Induced Tumor Immune Awakening via Suppressing the cGAS-STING Pathway in Hepatocellular Carcinoma. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2308009 |
| Yang X, Yang C, Zhang S, et al. (2024) Precision treatment in advanced hepatocellular carcinoma. Cancer Cell. 42: 180-197 |
| Li RS, Li LY, Zhu XF, et al. (2024) Annonaceous Acetogenins Synergistically Inhibit Hepatocellular Carcinoma with Sorafenib. Journal of Natural Products |
| Hong W, Zhang Y, Wang S, et al. (2023) Deciphering the immune modulation through deep transcriptomic profiling and therapeutic implications of DNA damage repair pattern in hepatocellular carcinoma. Cancer Letters. 216594 |
| Sun Y, Wu P, Zhang Z, et al. (2023) Integrated multi-omics profiling to dissect the spatiotemporal evolution of metastatic hepatocellular carcinoma. Cancer Cell |
| Zhou PY, Zhou C, Gan W, et al. (2023) Single-cell and spatial architecture of primary liver cancer. Communications Biology. 6: 1181 |
| Zhou C, Sun BY, Zhou PY, et al. (2023) MAIT cells confer resistance to Lenvatinib plus anti-PD1 antibodies in hepatocellular carcinoma through TNF-TNFRSF1B pathway. Clinical Immunology (Orlando, Fla.). 256: 109770 |